FORMULATION AND EVALUATION OF IN-SITU GEL CONTAINING CIPROFLOXACIN HYDROCHLORIDE IN THE TREATMENT OF PERIODONTITIS.

  • Gorle Ashish Department of Pharmaceutics, R C Patel Institute of Pharmaceutical Education and Research Shirpur, Dhule, Maharashtra 425405, India.
  • Yadav Rahul Department of Pharmaceutics, R C Patel Institute of Pharmaceutical Education and Research Shirpur, Dhule, Maharashtra 425405, India.
  • Rathod Mukesh Department of Pharmaceutics, R C Patel Institute of Pharmaceutical Education and Research Shirpur, Dhule, Maharashtra 425405, India.
  • Mali Prakash Department of Pharmaceutics, R C Patel Institute of Pharmaceutical Education and Research Shirpur, Dhule, Maharashtra 425405, India.

Abstract

Objective: The present study describes the use of in-situ gel in periodontal drug delivery systems which contains gellan gum (0.4–0.6% w/v), pluronic F127 (14, 15 and 16% w/v), and drug Ciprofloxacin HCl (0.1% w/v). Number of peoples around the world suffered from dental problem and ultimate fear is tooth loss hence in-situ gelling system was designed for the treatment of periodontal diseases. The therapeutic efficacy of drug can be greatly improved by prolonging its contact time.

Methods: Formulations were developed by simple solution method. Each formulation was characterized in terms of in gelling strength, viscosity, rheology, content uniformity, in vitro drug release, and syringeability.

Results: In vitro gelation time and the nature of the gel formed in simulated saliva for prepared formulations showed polymeric concentration dependency. Drug release data from all formulations was fitted to different kinetic models and the Korsemeyer-Peppas model was the best fit model. Drug release was significantly decreased as the concentration of each polymer component was increased. Increasing the concentration of each polymeric component significantly increased viscosity, syringeability, and time for 50%, 70%, and 90% drug release. In conclusion, the formulations described offer a wide range of physical and drug release characteristics. The formulation containing 0.6% w/v of gellan gum and 14% w/v of pluronic F127 exhibited superior physical characteristics. The formulation stored at 4ËšC before application, which is syringeable through 21 gauge needle.

Conclusion: This formulation was made to inject directly in to periodontal pocket where it immediately converts in to gel form at body temperature. 

Keywords: Periodontitis, Poloxamer 407, Gelation temperature, Syringeability, subgingival dental plaque.

References

1. Listgarten MA. Nature of periodontal diseases: Pathogenic mechanisms. J Periodontal Res 1987;22:172-8.
2. Slots J, Rams TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol 1990;17:479-93.
3. Medlicott NJ, Rathbone MJ, Tukcer IG, Holborow DW. Delivery systems for the administration of drugs to the periodontal pocket. Adv Drug Deliv Rev 1994;13:181-203.
4. Duchene D, Touchord F, Pappas NA. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm 1988;14:283.
5. Chen WG, George CC. Adhesive and in vitro release characteristics of propranolol bioadhesive disc system. Int J Pharm 1992;82:61-6.
6. Anshul S, Renu S. A review on levofloxacin in situ-gel formulation. Asian J Pharm Clin Res 2015;8(1):37-41.
7. Prakasam K, Bukka R. Evaluation of cellulose polymers for Buccal film formulation of rasagiline. Asian J Pharm Clin Res. 2014;7(3):83-7.
8. Ariyana A, David S, Irma E, Dan HB. Formulation and in vitro evaluation of alginate based metronidazole periodontal gel. Asian J Pharm Clin Res 2014;7(1):223-7.
9. ShahS, Bhadra S. Mucoadhesive in-situ gel for transmucosal delivery of celecoxib. Int J Pharm Pharm Sci 2014;6(10):221-7.
10. Harish NM, Prabhu P, Charyulu RN, Gulzar MA, Subrahmanyam CV. Formulation and evaluation of in situ gels containing clotrimazole for oral candidiasis. Indian J Pharm Sci 2009;71(4):421-7.
11. Edsman K, Carlfore J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci 1998;6:105-12.
12. Joshi M, Bolmal U, Dandagi P. Formulation and evaluation of cefuroxime axetil sol gel for periodontits. Int J Pharm Pharm Sci 2014;6(7):498-503.
13. Patel KS, Vadalia KR, Patel JK. Development and evaluation of in situ gelling system for treatment of periodontitis. Int J Pharm Tech Res 2014;6(7):2102-12.
14. Sapra P, Dhaval D, Soniwala M, Chavda J. Development and optimization of in situ periodontal gel containing levofloxacin for the treatment of periodontal diseases. J Sci Innov Res 2013;2(3):607-26.
15. Bachhav HD, Savkare A, Karmarkar R, Derle D. Development of poloxamer based thermosensitive in situ ocular gel of betaxolol hydrochloride. Int J Pharm Pharm Sci 2015;7(6):287-91
16. Rawat S, Warade S, Lahoti S. In situ gel formulation of ornidazole for the treatment of periodontal disease. Curr Pharm Res 2010;1:61-9.
17. Gorle AP, Gattani SG. Design and evaluation of polymeric ocular drug delivery system. Chem Pharm Bull 2009:57(9):914-9.
18. Partha N, Snigdha P, Laxmidhar M. Formulation development and in vitro evaluation of dental gel containing ethanol extract of Tephrosia Purpurea Linn. Int J Pharm Pharm Sci 2016;8(80):132-41.
Statistics
569 Views | 849 Downloads
Citatons
How to Cite
Ashish, G., Y. Rahul, R. Mukesh, and M. Prakash. “FORMULATION AND EVALUATION OF IN-SITU GEL CONTAINING CIPROFLOXACIN HYDROCHLORIDE IN THE TREATMENT OF PERIODONTITIS.”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, no. 6, June 2017, pp. 154-9, doi:10.22159/ajpcr.2017.v10i6.17558.
Section
Original Article(s)